An Assist for Arthritis Studies: A 3D Cell Culture of Human Fibroblast‐Like Synoviocytes by Encapsulation in a Chitosan‐Based Hydrogel

IF 3.7 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Francesco Bisconti, Beatrice Vilardo, Gaia Corallo, Francesca Scalera, Giuseppe Gigli, Annalisa Chiocchetti, Alessandro Polini, Francesca Gervaso
{"title":"An Assist for Arthritis Studies: A 3D Cell Culture of Human Fibroblast‐Like Synoviocytes by Encapsulation in a Chitosan‐Based Hydrogel","authors":"Francesco Bisconti, Beatrice Vilardo, Gaia Corallo, Francesca Scalera, Giuseppe Gigli, Annalisa Chiocchetti, Alessandro Polini, Francesca Gervaso","doi":"10.1002/adtp.202400166","DOIUrl":null,"url":null,"abstract":"Osteoarthritis (OA) and Rheumatoid arthritis (RA) are the most common arthritis in which the synovium is involved, but the cellular and molecular basis of these pathologies still need better elucidation. Fibroblast‐like synoviocytes (FLS), one of the cellular elements of the synovium, play a key role in RA, an autoimmune disease characterized by joint inflammation and systemic symptoms that afflicts 1% of worldwide population. Despite articular damage starts from synovium and then proceeds involving cartilage till bone erosion, several 3D in vitro models are reported for cartilage and bone while only a few studies focused on the synovial component. Here, a hydrogel formulation suitable for 3D culturing human fibroblast‐like synoviocytes and evaluated its suitability with non‐RA and RA patients derived‐cells is developed. Among different formulations, a chitosan (Cs)‐based hydrogel, constituted by 70% of Cs and 30% of Matrigel, showed the best results in terms of stability as well as cell growth and morphology: non‐RA and RA FLS are able to grow within the hydrogel forming a complex 3D network. Thanks to the low cost, and high market availability of chitosan, this system represents a good alternative to the use of sole Matrigel for encapsulating human synoviocytes.","PeriodicalId":7284,"journal":{"name":"Advanced Therapeutics","volume":"15 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/adtp.202400166","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Osteoarthritis (OA) and Rheumatoid arthritis (RA) are the most common arthritis in which the synovium is involved, but the cellular and molecular basis of these pathologies still need better elucidation. Fibroblast‐like synoviocytes (FLS), one of the cellular elements of the synovium, play a key role in RA, an autoimmune disease characterized by joint inflammation and systemic symptoms that afflicts 1% of worldwide population. Despite articular damage starts from synovium and then proceeds involving cartilage till bone erosion, several 3D in vitro models are reported for cartilage and bone while only a few studies focused on the synovial component. Here, a hydrogel formulation suitable for 3D culturing human fibroblast‐like synoviocytes and evaluated its suitability with non‐RA and RA patients derived‐cells is developed. Among different formulations, a chitosan (Cs)‐based hydrogel, constituted by 70% of Cs and 30% of Matrigel, showed the best results in terms of stability as well as cell growth and morphology: non‐RA and RA FLS are able to grow within the hydrogel forming a complex 3D network. Thanks to the low cost, and high market availability of chitosan, this system represents a good alternative to the use of sole Matrigel for encapsulating human synoviocytes.

Abstract Image

关节炎研究的辅助工具:用壳聚糖水凝胶包裹人纤维母细胞样滑膜细胞的三维细胞培养法
骨关节炎(OA)和类风湿性关节炎(RA)是滑膜受累的最常见关节炎,但这些病症的细胞和分子基础仍有待进一步阐明。成纤维细胞样滑膜细胞(FLS)是滑膜的细胞成分之一,在 RA 中起着关键作用,RA 是一种自身免疫性疾病,以关节炎症和全身症状为特征,全球 1%的人患有 RA。尽管关节损伤从滑膜开始,然后涉及软骨直至骨侵蚀,但目前已有一些针对软骨和骨的三维体外模型的报道,而针对滑膜成分的研究却寥寥无几。在此,我们开发了一种适用于三维培养人成纤维细胞样滑膜细胞的水凝胶配方,并对其与非 RA 和 RA 患者衍生细胞的适用性进行了评估。在不同的配方中,由 70% 的 Cs 和 30% 的 Matrigel 组成的壳聚糖(Cs)水凝胶在稳定性、细胞生长和形态方面显示出最佳效果:非 RA 和 RA FLS 能够在水凝胶中生长,形成复杂的三维网络。由于壳聚糖成本低廉,市场供应充足,因此该系统是封装人体滑膜细胞的良好替代品,而非仅使用 Matrigel。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced Therapeutics
Advanced Therapeutics Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
7.10
自引率
2.20%
发文量
130
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信